Lin Patrick's Form 4 filing
Processa Pharmaceuticals, Inc. (PCSA) · filed Feb 1, 2024
- Accession no.
- 0000897069-24-000236
- Filed
- Feb 1, 2024
- Trade date
- Jan 31-Feb 1, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $9.53K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lin PatrickCIK 0001799363 | Officer (Chief Business - Strategy Off) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | Common Stock | PPurchaseAcquired | +2,500 | $2.37 | +$5,925 | 25,978 | Direct | |
| Feb 1, 2024 | Common Stock | PPurchaseAcquired | +1,500 | $2.40 | +$3,600 | 27,478 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.